The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls

Acta Paediatrica, International Journal of Paediatrics

Volumn 104, Issue 4, 2015, Pages e171-e177

  Akin, Leyla ^a   Kendirci, Mustafa ^a   Narin, Figen ^a   Kurtoglu, Selim ^a   Saraymen, Recep ^a   Kondolot, Meda ^a   Koçak, Selda ^a   Elmali, Ferhan ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Adolescents; Bisphenol A; Endocrine disruptors; Polycystic ovary syndrome

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; PRASTERONE SULFATE; TESTOSTERONE; BENZHYDRYL DERIVATIVE; ENDOCRINE DISRUPTOR; PHENOL DERIVATIVE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERBARISM; INSULIN RESISTANCE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; BLOOD; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; YOUNG ADULT;

ADOLESCENT; BENZHYDRYL COMPOUNDS; CROSS-SECTIONAL STUDIES; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; PHENOLS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84925295093     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12885     Document Type: Article

References (29)

1. Biro FM, Emans SJ,. Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls. J Adolesc Health 2008; 43: 103-5.
2. Glintborg D, Andersen M,. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol 2010; 26: 281-96.
3. Lakkakula BV, Thangavelu M, Godla UR,. Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review. J Assist Reprod Genet 2013; 30: 883-95.
4. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009; 30: 293-342.
5. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300: 1303-10.
6. Melzer D, Gates P, Osborn NJ, Henley WE, Cipelli R, Young A, et al. Urinary bisphenol a concentration and angiography-defined coronary artery stenosis. PLoS One 2012; 7: e43378.
7. Newbold RR, Jefferson WN, Padilla-Banks E,. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 2007; 24: 253-8.
8. Grasselli F, Baratta L, Baioni L, Bussolati S, Ramoni R, Grolli S, et al. Bisphenol A disrupts granulosa cell function. Domest Anim Endocrinol 2010; 39: 34-9.
9. Fernandez M, Bourguignon N, Lux-Lantos V, Libertun C,. Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect 2010; 118: 1217-22.
10. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y,. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004; 51: 165-9.
11. Kandaraki E, Chatzigeorgiou A, Livadas S, Palioura E, Economou F, Koutsilieris M, et al. Endocrine disruptors and Polycystic Ovary Syndrome (PCOS): elevated serum levels of Bisphenol A in women with PCOS. J Clin Endocrinol Metab 2011; 96: 480-4.
12. Tarantino G, Valentino R, Di Somma C, D'Esposito V, Passaretti F, Pizza G, et al. Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf) 2013; 78: 447-53.
13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
14. Ozturk A, Mazicioglu MM, Hatipoglu N, Budak N, Keskin G, Yazlak Z, et al. Reference body mass index curves for Turkish children 6 to 18 years of age. J Pediatr Endocrinol Metab 2008; 21: 827-36.
15. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003; 88: 4682-8.
16. Xiao Q, Li Y, Ouyang H, Xu P, Wu D,. High-performance liquid chromatographic analysis of bisphenol A and 4-nonylphenol in serum, liver and testis tissues after oral administration to rats and its application to toxicokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 830: 322-9.
17. Foster WG, Neal MS, Han MS, Dominguez MM,. Environmental contaminants and human infertility: hypothesis or cause for concern? J Toxicol Environ Health B Crit Rev 2008; 11: 162-76.
18. Pasquali R, Stener-Victorin E, Yildiz BO, Duleba AJ, Hoeger K, Mason H, et al. Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) 2011; 74: 424-33.
19. Takeuchi T, Tsutsumi O,. Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun 2002; 291: 76-8.
20. Zhou W, Liu J, Liao L, Han S, Liu J,. Effect of Bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrinol 2008; 283: 12-8.
21. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 5925-33.
22. Hanioka N, Jinno H, Nishimura T, Ando M,. Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver. Arch Toxicol 1998; 72: 387-94.
23. Takeuchi T, Tsutsumi O, Ikezuki Y, Kamei Y, Osuga Y, Fujiwara T, et al. Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity. Endocr J 2006; 53: 485-91.
24. Bondesson M, Jönsson J, Pongratz I, Olea N, Cravedi JP, Zalko D, et al. A CASCADE of effects of bisphenol A. Reprod Toxicol 2009; 28: 563-7.
25. Silver MK, O'Neill MS, Sowers MR, Park SK,. Urinary bisphenol A and type-2 diabetes in U.S. adults: data from NHANES 2003-2008. PLoS One 2011; 6: e26868.
26. Wang T, Li M, Chen B, Xu M, Xu Y, Huang Y, et al. Urinary bisphenol A (B̄SPHENOL A) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012; 97: 223-7.
27. Wada K, Sakamoto H, Nishikawa K, Sakuma S, Nakajima A, Fujimoto Y, et al. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci 2007; 105: 133-7.
28. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquié M, Gauthier BR, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008; 3: 2069.
29. Rochester JR,. Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013; 42: 132-55.